D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 48 Citations 18,217 107 World Ranking 13870 National Ranking 237

Overview

What is he best known for?

The fields of study Tom Vanden Berghe is best known for:

  • Apoptosis
  • Immune system
  • Enzyme

Tom Vanden Berghe bridges between several scientific fields such as Tumor necrosis factor alpha, Immune system, Sepsis and Inflammation in his study of Immunology. His Immunology research extends to Tumor necrosis factor alpha, which is thematically connected. He performs multidisciplinary study in the fields of Immune system and Programmed cell death via his papers. Tom Vanden Berghe integrates many fields, such as Inflammation and Programmed cell death, in his works. While working in this field, Tom Vanden Berghe studies both Apoptosis and Innate immune system. His Cell biology study frequently links to other fields, such as Kinase. Kinase is closely attributed to Cell biology in his work. Tom Vanden Berghe integrates Genetics and Cancer research in his studies. He merges many fields, such as Cancer research and Genetics, in his writings.

His most cited work include:

  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (3091 citations)
  • Molecular mechanisms of necroptosis: an ordered cellular explosion (1856 citations)
  • Regulated necrosis: the expanding network of non-apoptotic cell death pathways (1249 citations)

What are the main themes of his work throughout his whole career to date

In most of his Cell biology studies, his work intersects topics such as Kinase and Signal transduction. Much of his study explores Signal transduction relationship to Cell biology. Immunology is intertwined with Inflammation, Tumor necrosis factor alpha and Immune system in his research. By researching both Inflammation and Programmed cell death, Tom Vanden Berghe produces research that crosses academic boundaries. Tom Vanden Berghe performs multidisciplinary studies into Immune system and Immunology in his work. He conducts interdisciplinary study in the fields of Apoptosis and Tumor necrosis factor alpha through his research. His work often combines Biochemistry and Gene studies. He integrates Gene with Programmed cell death in his study. Tom Vanden Berghe conducted interdisciplinary study in his works that combined Genetics and Cell.

Tom Vanden Berghe most often published in these fields:

  • Apoptosis (74.03%)
  • Programmed cell death (71.43%)
  • Cell biology (66.23%)

What were the highlights of his more recent work (between 2019-2022)?

  • Biochemistry (77.78%)
  • Programmed cell death (66.67%)
  • Apoptosis (66.67%)

In recent works Tom Vanden Berghe was focusing on the following fields of study:

Tom Vanden Berghe conducted interdisciplinary study in his works that combined Biochemistry and Bioinformatics. His Bioinformatics study frequently draws connections to adjacent fields such as Microbiome. In his study, he carries out multidisciplinary Microbiome and Immune system research. By researching both Immune system and Homeostasis, he produces research that crosses academic boundaries. Many of his studies on Homeostasis apply to Cell biology as well. He regularly ties together related areas like Kinase in his Cell biology studies. Kinase and Biochemistry are commonly linked in his work. He merges Programmed cell death with Caspase in his research. Tom Vanden Berghe undertakes multidisciplinary investigations into Caspase and RIPK1 in his work.

Between 2019 and 2022, his most popular works were:

  • Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer (92 citations)
  • Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID‐19): autopsy reveals a ferroptosis signature (65 citations)
  • Withaferin A: From ayurvedic folk medicine to preclinical anti-cancer drug (61 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Molecular mechanisms of necroptosis: an ordered cellular explosion.

Peter Vandenabeele;Lorenzo Galluzzi;Lorenzo Galluzzi;Tom Vanden Berghe;Guido Kroemer.
Nature Reviews Molecular Cell Biology (2010)

2334 Citations

Regulated necrosis: the expanding network of non-apoptotic cell death pathways

Tom Vanden Berghe;Andreas Linkermann;Sandrine Jouan-Lanhouet;Henning Walczak.
Nature Reviews Molecular Cell Biology (2014)

1572 Citations

Targeting Ferroptosis to Iron Out Cancer.

Behrouz Hassannia;Peter Vandenabeele;Tom Vanden Berghe.
Cancer Cell (2019)

911 Citations

Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response.

Nele Festjens;Tom Vanden Berghe;Peter Vandenabeele.
Biochimica et Biophysica Acta (2006)

888 Citations

Apoptosis and necrosis: detection, discrimination and phagocytosis.

Dmitri V. Krysko;Tom Vanden Berghe;Katharina D’Herde;Peter Vandenabeele.
Methods (2008)

862 Citations

The molecular machinery of regulated cell death

Daolin Tang;Rui Kang;Tom Vanden Berghe;Peter Vandenabeele;Peter Vandenabeele.
Cell Research (2019)

839 Citations

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

Lorenzo Galluzzi;Ilio Vitale;Stuart A. Aaronson;John M. Abrams.
Nature (2018)

784 Citations

Neutrophil extracellular trap cell death requires both autophagy and superoxide generation.

Quinten Remijsen;Tom Vanden Berghe;Ellen Wirawan;Bob Asselbergh.
Cell Research (2011)

743 Citations

Synchronized renal tubular cell death involves ferroptosis

Andreas Linkermann;Rachid Skouta;Nina Himmerkus;Shrikant R. Mulay.
Proceedings of the National Academy of Sciences of the United States of America (2014)

681 Citations

RIP Kinases at the Crossroads of Cell Death and Survival

Wim Declercq;Tom Vanden Berghe;Peter Vandenabeele.
Cell (2009)

550 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Tom Vanden Berghe

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 141

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 138

Peter Vandenabeele

Peter Vandenabeele

Ghent University

Publications: 127

Simone Fulda

Simone Fulda

Goethe University Frankfurt

Publications: 77

Andreas Linkermann

Andreas Linkermann

TU Dresden

Publications: 63

James M. Murphy

James M. Murphy

Walter and Eliza Hall Institute of Medical Research

Publications: 58

Oliver Kepp

Oliver Kepp

Institut Gustave Roussy

Publications: 57

Junying Yuan

Junying Yuan

Harvard University

Publications: 55

John Silke

John Silke

Walter and Eliza Hall Institute of Medical Research

Publications: 54

Thirumala-Devi Kanneganti

Thirumala-Devi Kanneganti

St. Jude Children's Research Hospital

Publications: 51

Douglas R. Green

Douglas R. Green

St. Jude Children's Research Hospital

Publications: 50

Dmitri V. Krysko

Dmitri V. Krysko

Ghent University

Publications: 47

Laurence Zitvogel

Laurence Zitvogel

University of Paris-Saclay

Publications: 44

Brent R. Stockwell

Brent R. Stockwell

Columbia University

Publications: 37

Marcus Conrad

Marcus Conrad

Helmholtz Zentrum München

Publications: 37

Gerry Melino

Gerry Melino

University of Rome Tor Vergata

Publications: 34

Trending Scientists

Chunyuan Li

Chunyuan Li

Microsoft (United States)

Kwanghee Nam

Kwanghee Nam

Pohang University of Science and Technology

Stephen B. H. Kent

Stephen B. H. Kent

University of Chicago

Paolo Falcaro

Paolo Falcaro

Graz University of Technology

Leif Asbjørn Vøllestad

Leif Asbjørn Vøllestad

University of Oslo

Emilio Nicolás

Emilio Nicolás

Spanish National Research Council

Anders Løbner-Olesen

Anders Løbner-Olesen

University of Copenhagen

Giovanni Widmer

Giovanni Widmer

Tufts University

Robert D. Rosenberg

Robert D. Rosenberg

Technical University of Munich

John J. Goering

John J. Goering

University of Alaska Fairbanks

Robert D. Foreman

Robert D. Foreman

University of Oklahoma Health Sciences Center

Richard S. Lazarus

Richard S. Lazarus

University of California, Berkeley

Thomas Reinehr

Thomas Reinehr

Boston Children's Hospital

James L. Kirkland

James L. Kirkland

Mayo Clinic

Eduardo Bruera

Eduardo Bruera

The University of Texas MD Anderson Cancer Center

Stephen R. Barley

Stephen R. Barley

Stanford University

Something went wrong. Please try again later.